These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22698186)

  • 1. Current status of chemokine receptor inhibitors in development.
    Allegretti M; Cesta MC; Garin A; Proudfoot AE
    Immunol Lett; 2012 Jul; 145(1-2):68-78. PubMed ID: 22698186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptors: attractive targets for drug discovery.
    Godessart N
    Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery and chemokine receptor antagonists: eppur si muove!
    Terricabras E; Benjamim C; Godessart N
    Autoimmun Rev; 2004 Nov; 3(7-8):550-6. PubMed ID: 15546804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-chemokine small molecule drugs: a promising future?
    Proudfoot AE; Power CA; Schwarz MK
    Expert Opin Investig Drugs; 2010 Mar; 19(3):345-55. PubMed ID: 20113217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine network, a newly discovered target in high grade gliomas.
    Domanska UM; Kruizinga RC; den Dunnen WF; Timmer-Bosscha H; de Vries EG; Walenkamp AM
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):154-63. PubMed ID: 20709564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z; Koch AE; Tak PP
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine network: a target in cancer biology?
    Slettenaar VI; Wilson JL
    Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?
    Wise E; Pease JE
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):755-9. PubMed ID: 17635141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X; Oppenheim JJ; Howard OM
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
    Elsner J; Escher SE; Forssmann U
    Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ; Oostendorp RL; Tak PP
    Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting chemokines: Pathogens can, why can't we?
    Proudfoot AE; Bonvin P; Power CA
    Cytokine; 2015 Aug; 74(2):259-67. PubMed ID: 25753743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of leukocyte recruitment in inflammatory diseases.
    Szekanecz Z; Koch AE
    Curr Opin Pharmacol; 2004 Aug; 4(4):423-8. PubMed ID: 15251139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine blockers--therapeutics in the making?
    Wells TN; Power CA; Shaw JP; Proudfoot AE
    Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
    Russo RC; Garcia CC; Teixeira MM
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):414-27. PubMed ID: 20597027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in chemokines and chemokine receptors.
    Zlotnik A; Morales J; Hedrick JA
    Crit Rev Immunol; 1999; 19(1):1-47. PubMed ID: 9987599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the chemokine network in renal inflammation.
    Eis V; Vielhauer V; Anders HJ
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):164-72. PubMed ID: 15247883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.